Eko Foundation Analysis Software with Transformers (EFAST) vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

EFAST is designed for real-time diagnostic assistance during clinical exams, leveraging AI with digital stethoscopes to detect structural murmurs and atrial fibrillation. In contrast, Verily Study Watch is a wearable device focused on continuous physiological monitoring and data collection for clinical research purposes. While both utilize AI in cardiology, their primary applications and user interfaces are distinct, with EFAST supporting immediate clinical decisions and Study Watch facilitating long-term data acquisition for studies.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, AI-powered diagnostic assistance during routine patient auscultation. This tool is ideal for clinicians seeking immediate insights into structural murmurs and atrial fibrillation at the point of care, streamlining cardiac screenings and improving diagnostic efficiency during patient visits.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose Study Watch if…

Choose Verily Study Watch if your objective is continuous, long-term physiological data collection for clinical research studies. This wearable is best suited for researchers requiring extensive, multi-sensor data (ECG, heart rate, movement) over extended periods to analyze trends and develop insights into various cardiac, neurological, or sleep-related conditions.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) Study Watch
Pricing Subscription-based, contact for details Unknown
Deployment Unknown The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST integrates directly into a clinician's routine auscultation workflow, providing real-time, actionable insights and guided exams. This direct, immediate feedback during patient interaction makes it highly usable for clinical practice compared to a wearable device primarily for continuous data collection in research.

Clinical Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST provides immediate, high-accuracy diagnostic assistance for structural murmurs and AFib with strong sensitivity and specificity figures (93% sensitivity, 91% specificity for structural murmur detection; 95% sensitivity, 94% specificity for AFib detection). While Study Watch collects valuable continuous physiological data for research and can monitor irregular pulse, EFAST offers direct, real-time clinical decision support at the point of care.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers more transparent pricing information, clearly stating it's subscription-based and providing a daily cost for its hardware. In contrast, Study Watch's pricing is not publicly available, making it difficult for potential users to assess its value proposition without direct contact for details.

Enterprise Readiness

Eko Foundation Analysis Software with Transformers (EFAST)

Both tools are FDA-cleared and cloud-based with HIPAA compliance claims. However, the ongoing lawsuit alleging BAA breaches and HIPAA violations against Verily (Tool B), even if denied, introduces a significant potential compliance risk for enterprise adoption that Tool A does not currently face.

Innovation

Tie

EFAST innovates by integrating real-time AI diagnostics directly into the traditional auscultation workflow, providing immediate clinical insights. Study Watch demonstrates innovation through its multi-sensor continuous physiological monitoring for research, enabling new avenues for data collection and analysis in understanding health and disease. Both represent significant advancements in their respective domains.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health (Tool A) provides readily accessible public-facing support resources, including FAQs, user manuals, and troubleshooting guides on its website. Verily Study Watch (Tool B), being primarily for clinical research and partnerships, has less publicly available end-user support documentation, implying support is handled through research agreements rather than general public access.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) Study Watch
Name Eko Foundation Analysis Software with Transformers (EFAST) Study Watch
Company Eko Health Verily Life Sciences
Primary Function Advanced, FDA-cleared AI model assisting clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Key AI/Monitoring Capabilities AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation; Enhanced audio with noise cancellation and amplification; Waveform visualization and guided exams; Seamless integration with Eko digital stethoscopes; Cloud-based recording and secure storage of exams; EMR integration. Continuous physiological monitoring; Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements); Long battery life (up to one week); Internal data storage and encryption; Cloud-based data processing with algorithms and machine learning; On-demand single-channel ECG; Irregular pulse monitor; E-ink display.
Supported Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Neurology, Sleep Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EFAST by Eko Health is an advanced AI model designed to assist clinicians in real-time identification of structural murmurs associated with heart disease and detection of atrial fibrillation during routine exams. In contrast, Verily Study Watch is a prescription-only wearable device for non-invasive, continuous physiological monitoring primarily used in clinical research, collecting data like ECG and heart rate for analysis in Verily's cloud platform.
EFAST integrates seamlessly with Eko digital stethoscopes, leveraging AI analysis during auscultation. Verily Study Watch is a wearable device with multiple physiological sensors, including ECG, heart rate, electrodermal activity, and inertial movements, collecting data from the wrist.
EFAST is specifically cleared for AI-powered detection of structural murmurs (93% sensitivity, 91% specificity) and atrial fibrillation (95% sensitivity, 94% specificity). The Verily Study Watch offers on-demand single-channel ECG and an irregular pulse monitor, with its continuous monitoring capabilities being utilized in research for conditions like atrial fibrillation and heart failure.
Both tools are FDA-cleared, HIPAA compliant, and have Business Associate Agreements (BAAs). However, Verily, the company behind Study Watch, is currently facing an ongoing lawsuit alleging HIPAA violations and breaches of BAAs, which Verily denies.

Backers

Who funded each tool's parent company.

Eko Foundation Analysis Software with Transformers (EFAST)

AI Tool Finder
AI-powered search. Results may not be comprehensive.